CMMBVSCTSO• 12 Months (Normalized)
CMMB vs CTSO (Chemomab Therapeutics Ltd. vs Cytosorbents Corporation)
Showing Closing Date Range from Sep 29, 2025 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
-36.98%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
CTSO Performance $4.91
+%
Cytosorbents Corporation
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
-36.98 pts
CTSO outperforming by 36.98 percentage points
CMMBCTSO
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB CTSO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | CMMB Price | CMMB Gain (%) | CTSO Price | CTSO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | -36.98% | $- | - | |
| Sep 28, 2026 | $1.64 | -38.11% | $- | - | |
| Sep 25, 2026 | $2.16 | -18.49% | $- | - | |
| Sep 24, 2026 | $2.20 | -16.98% | $- | - | |
| Sep 23, 2026 | $2.28 | -13.96% | $4.91 | +430.81% | -444.77% |
| Sep 22, 2026 | $2.51 | -5.28% | $- | - | |
| Sep 21, 2026 | $2.48 | -6.42% | $5.51 | +495.68% | -502.10% |
| Sep 18, 2026 | $2.61 | -1.51% | $5.75 | +521.62% | -523.13% |
| Sep 17, 2026 | $2.80 | +5.66% | $5.76 | +522.70% | -517.04% |
| Sep 16, 2026 | $2.65 | +0.00% | $5.73 | +519.46% | -519.46% |
| Sep 15, 2026 | $2.47 | -6.79% | $6.06 | +555.14% | -561.93% |
| Sep 14, 2026 | $2.45 | -7.55% | $6.07 | +556.22% | -563.77% |
| Sep 11, 2026 | $2.58 | -2.64% | $6.41 | +592.97% | -595.61% |
| Sep 10, 2026 | $2.60 | -1.89% | $6.37 | +588.65% | -590.54% |
| Sep 09, 2026 | $2.69 | +1.51% | $6.33 | +584.32% | -582.81% |
Page 1 of 17